See our Annual Report 2019!
Congratulations to Prof. Elisa Oricchio, supported by the ISREC Foundation, for her publication in the renowned journal “Cancer Cell”. This article explains how the immune system can be directed against lymphomas.
Research led by Prof. Ping-Chih Ho of the Ludwig Lausanne branch has identified a mechanism by which regulatory T cells adapt their metabolism to thrive in the harsh microenvironment of the tumor. His investigations are supported by the ISREC Foundation.
Congratulations to Prof. Fabrice André, member of our Scientific Board, on his appointment as the research director of the Gustave Roussy Institute in Villejuif.
More information in the press release (in French)
Congratulations to the teams of Prof. George Coukos and Prof. Melita Irving, both working at CHUV/UNIL. In collaboration with EPFL scientists, they have developed a system to counter certain toxic side effects of immunotherapies, thus providing new hope for the treatment of solid tumors. Their research is supported by the ISREC Foundation.
Congratulations to Prof. Douglas Hanahan who is being appointed Distinguished Scholar of Ludwig. A pioneering molecular biologist and renowned cancer researcher, Douglas Hanahan is director of ISREC@epfl since 2009.
World Cancer Day takes place every year on February 4 to unite the world in the fight against cancer. This day aims to raise awareness by spreading information concerning the disease.
Congratulations to Efe Erdes for his publication in the “Journal for ImmunoTherapy of Cancer”. His article describes the chronic TCR-MHC interactions that limit the functional potential of TCR affinity-increased CD8 T lymphocytes. His research, performed in the lab of Dr. Nathalie Rufer (Oncology Department, UNIL/CHUV), was supported by the ISREC foundation.
Congratulations to Prof David Gfeller (UNIL/SIB), Dr. Michal Bassani-Sternberg (CHUV/UNIL) and Julien Racle (UNIL/SIB): the results of their work provide new perspectives for both immunotherapy and basic research regarding the interaction between cancer and the immune system. These investigations are supported by the ISREC Foundation.
More information (in French)
and in the journal Nature Biotechnology
Congratulations are in order for the research teams of Prof. Douglas Hanahan, director of the ISREC@epfl. Their work has led to the identification of a signaling pathway used by mammary tumors to form metastases in the brain. This discovery has been published in the prestigious journal Nature.